glp-1 7-36 (7-36) amide | Sterile (Ser8)-GLP-1 (7-36), amide, human

For patients seeking weight loss who request B12 injections, GPs should: Assess for genuine deficiency through appropriate blood tests rather than empirical treatment Provide education about the lack of evidence supporting B12 for weight loss in non-deficient individuals Explore underlying concerns about weight and energy levels, addressing these through appropriate channels Signpost to evidence-based resources such as NHS weight management services according to local pathways Patients should contact their GP if they experience unexplained fatigue, neurological symptoms (numbness, tingling, balance problems), or signs of anaemia (pallor, breathlessness, palpitations), as these may indicate B12 deficiency requiring investigation

In addition, fewer semaglutide-treated patients experienced deterioration in NYHA functional class (2.09% versus 5.24%, respectively

Nate Ruch Topics Hormone replacement therapy (HRT) + GLP-1 treatment key points: Safe and effective hormone replacement therapy (HRT) is available for both men and women, backed by decades of data showing that the benefits can outweigh risks for most patients

Safety-wise, handle the powder using gloves and in a clean environment